Suppr超能文献

阿魏酸在特定恶性肿瘤中的作用。

The Role of Ferulic Acid in Selected Malignant Neoplasms.

作者信息

Markowska Anna, Markowska Janina, Stanisławiak-Rudowicz Joanna, Kozak Katarzyna, Roubinek Otton Krzysztof, Jasińska Magdalena

机构信息

Department of Perinatology, Poznań University of Medical Science, 60-535 Poznań, Poland.

Gynecologic Oncology Center Poznań, Poznańska 58A, 60-850 Poznań, Poland.

出版信息

Molecules. 2025 Feb 23;30(5):1018. doi: 10.3390/molecules30051018.

Abstract

Ferulic acid (FA) is a polyphenol that is found in plants and fruits. It has a wide range of anticancer properties, including participating in cell apoptosis, inhibiting invasion and angiogenesis, and acting synergistically with standard cytostatic agents in malignant tumors. A range of molecular mechanisms are involved in anticancer activity and include the following ones: activation of cell-cycle-related proteins and enzymes such as p53, p21, Bax, and pro-caspases 3 and 9, reduction of cyclin D1 and E, proapoptotic Bcl-2, MMP-9, and NF-kV, which decrease VEGF, leading to cell cycle arrest at G0/G1 phase and death of cancer cells. Other mechanisms inhibit several pathways: PI3K/AKT/mTOR, Notch, and Wnt, which are associated with downregulation of proliferation, invasion, metastasis, and angiogenesis. FA can induce activation of ROS, leading to DNA damage in cancer cells. In vitro and in vivo studies have demonstrated the significant antitumor activity of FA in breast cancer, particularly when used in combination with cytostatic agents. In vitro studies on cervical cancer cell lines have reported similar anticancer activity of FA. This includes inhibition of cell proliferation and induction of apoptosis by downregulating antiapoptotic proteins. A case-control study conducted in Italy found that men with histologically confirmed prostate cancer had notably lower levels of FA compared to controls. Molecular in vitro studies have suggested that FA may have various effects on the signaling pathways linked to a reduction in the risk of prostate cancer, and it may act in synergy with δ-tocotrienol, which is a derivative of vitamin E. In vivo and in vitro studies on colorectal cancer have demonstrated the effects of FA on the early development of this cancer-inhibition of abnormal crypt foci (ACF-aberrant crypt foci), as well as the reduction in cancer cell viability and apoptosis through molecular changes, mainly a decrease in EGFR expression. The poor water solubility of FA makes it an attractive candidate for use as nanoparticles.

摘要

阿魏酸(FA)是一种存在于植物和水果中的多酚。它具有广泛的抗癌特性,包括参与细胞凋亡、抑制侵袭和血管生成,以及在恶性肿瘤中与标准细胞抑制剂协同作用。一系列分子机制参与抗癌活性,包括以下方面:激活细胞周期相关蛋白和酶,如p53、p21、Bax以及前半胱天冬酶3和9;降低细胞周期蛋白D1和E、促凋亡Bcl-2、基质金属蛋白酶-9和核因子κB,从而减少血管内皮生长因子(VEGF),导致细胞周期停滞在G0/G1期并使癌细胞死亡。其他机制抑制多种途径:磷脂酰肌醇-3激酶/蛋白激酶B/哺乳动物雷帕霉素靶蛋白(PI3K/AKT/mTOR)、Notch和Wnt途径,这些途径与增殖、侵袭、转移和血管生成的下调相关。FA可诱导活性氧(ROS)激活,导致癌细胞DNA损伤。体外和体内研究均表明FA在乳腺癌中具有显著的抗肿瘤活性,尤其是与细胞抑制剂联合使用时。对宫颈癌细胞系的体外研究报告了FA类似的抗癌活性。这包括通过下调抗凋亡蛋白抑制细胞增殖和诱导凋亡。在意大利进行的一项病例对照研究发现,经组织学确诊的前列腺癌男性患者的FA水平明显低于对照组。分子体外研究表明,FA可能对与降低前列腺癌风险相关的信号通路有多种作用,并且可能与维生素E的衍生物δ-生育三烯酚协同作用。对结直肠癌的体内和体外研究表明,FA对这种癌症的早期发展有影响——抑制异常隐窝灶(ACF),以及通过分子变化降低癌细胞活力并诱导凋亡,主要是表皮生长因子受体(EGFR)表达的降低。FA的水溶性差使其成为用作纳米颗粒的有吸引力的候选物。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3e16/11901789/8afcf18c20b3/molecules-30-01018-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验